4568:TYO
Daiichi Sankyo Co Ltd
2 709,00 JP¥
arrow_downward
-1,15%(-31,50) 1K
2-okt, 15:30:00 (GMT+9) · JPY
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto4568 tikeri uchun statistika yaratilmoqda...
Ochish
2 720 JP¥
Yuqori
2 751 JP¥
Past
2 704 JP¥
Bozor kapitali
5,05 trln
Oʻrtacha hajm
6,01 mln
Hajmi
5,14 mln
Dividend
2,88%
Choraklik dividendlar
20 JP¥
P/E koeffitsiyenti
20,52
52 haftalik eng yuqori
4 178 JP¥
52 haftalik eng past
2 390 JP¥
Aksiya boʻyicha daromad
132 JP¥
Muomaladagi aksiyalar
647,77 mln
Xodimlar soni
20 ming
Ochish
2 720 JP¥
Yuqori
2 751 JP¥
Past
2 704 JP¥
Bozor kapitali
5,05 trln
Oʻrtacha hajm
6,01 mln
Hajmi
5,14 mln
Dividend
2,88%
Choraklik dividendlar
20 JP¥
P/E koeffitsiyenti
20,52
52 haftalik eng yuqori
4 178 JP¥
52 haftalik eng past
2 390 JP¥
Aksiya boʻyicha daromad
132 JP¥
Muomaladagi aksiyalar
647,77 mln
Xodimlar soni
20 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
1 soat oldin
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
Seeking Alpha
·
1 soat oldin
AstraZeneca, Daiichi Sankyo collaborate with Summit Therapeutics to evaluate Datroway-ivonescimab combo
TipRanks
·
1 soat oldin
AstraZeneca, Daiichi Sankyo and Summit expand ADC–immunotherapy push with Datroway–ivonescimab trials
Investing.com UK
·
1 soat oldin
AstraZeneca, Daiichi Sankyo partner with Summit on cancer trial By Investing.com
Profil
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Daiichi Sankyo Co Ltd haqida
CEOHiroyuki Okuzawa
Xodimlar soni20,2 ming
Asos solingan28-sen, 2005
Bosh ofislarChuo City, Tokio, Yaponiya
Sektor-
Veb-saytdaiichisankyo.co.jp